Horizon Kinetics Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $6.97 Billion
- Q3 2025
A detailed history of Horizon Kinetics Asset Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 2,480 shares of ALNY stock, worth $1.11 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,480
Previous 2,759
10.11%
Holding current value
$1.11 Million
Previous $899,000
25.7%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ALNY
# of Institutions
925Shares Held
117MCall Options Held
1.25MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...